Sunshine law could speed or slow spending on doctors

09/3/2013 | Genetic Engineering & Biotechnology News

The effect of disclosure on payments to doctors under the Physician Payments Sunshine Act by pharmaceutical companies isn't yet clear, experts say. Whether drugmakers' spending will go up or down "is the $64,000 question," said Kendra Martello, PhRMA's deputy vice president for state advocacy.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs: